Basal Cell Signaling by p63 Controls Luminal Progenitor Function and Lactation via NRG1

Developmental Cell

Volumn 28, Issue 2, 2014, Pages 147-160

  Forster, Nicole ^a   Saladi, SrinivasVinod ^a   vanBragt, Maaike ^b   Sfondouris, MaryE ^c   Jones, FrankE ^c   Li, Zhe ^b   Ellisen, LeifW ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Tulane University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NRG1 PROTEIN; PROTEIN P63; STAT5A PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM BASAL CELL; FEMALE; GENE; GENE DELETION; LACTATION; MILK PRODUCTION; MOUSE; NONHUMAN; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION INITIATION;

ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE DELETION; HEK293 CELLS; HUMANS; LACTATION; MAMMARY GLANDS, ANIMAL; MICE; NEUREGULIN-1; PARACRINE COMMUNICATION; PHOSPHOPROTEINS; PREGNANCY; RECEPTOR, EPIDERMAL GROWTH FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84893004671     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2013.11.019     Document Type: Article

References (51)

1. Asselin-Labat M.L., Sutherland K.D., Barker H., Thomas R., Shackleton M., Forrest N.C., Hartley L., Robb L., Grosveld F.G., van der Wees J., et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 2007, 9:201-209.
2. Badders N.M., Goel S., Clark R.J., Klos K.S., Kim S., Bafico A., Lindvall C., Williams B.O., Alexander C.M. The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage. PLoS ONE 2009, 4:e6594.
3. Barton C.E., Johnson K.N., Mays D.M., Boehnke K., Shyr Y., Boukamp P., Pietenpol J.A. Novel p63 target genes involved in paracrine signaling and keratinocyte differentiation. Cell Death Dis. 2010, 1:e74.
4. Brisken C., Kaur S., Chavarria T.E., Binart N., Sutherland R.L., Weinberg R.A., Kelly P.A., Ormandy C.J. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev. Biol. 1999, 210:96-106.
5. Brisken C., Heineman A., Chavarria T., Elenbaas B., Tan J., Dey S.K., McMahon J.A., McMahon A.P., Weinberg R.A. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 2000, 14:650-654.
6. Carroll D.K., Carroll J.S., Leong C.O., Cheng F., Brown M., Mills A.A., Brugge J.S., Ellisen L.W. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat. Cell Biol. 2006, 8:551-561.
7. Ciarloni L., Mallepell S., Brisken C. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc. Natl. Acad. Sci. USA 2007, 104:5455-5460.
8. Cui Y., Riedlinger G., Miyoshi K., Tang W., Li C., Deng C.X., Robinson G.W., Hennighausen L. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol. Cell. Biol. 2004, 24:8037-8047.
9. Emanuel S.L., Hughes T.V., Adams M., Rugg C.A., Fuentes-Pesquera A., Connolly P.J., Pandey N., Moreno-Mazza S., Butler J., Borowski V., et al. Cellular and invivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors. Mol. Pharmacol. 2008, 73:338-348.
10. Fata J.E., Kong Y.Y., Li J., Sasaki T., Irie-Sasaki J., Moorehead R.A., Elliott R., Scully S., Voura E.B., Lacey D.L., et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000, 103:41-50.
11. Ferone G., Thomason H.A., Antonini D., De Rosa L., Hu B., Gemei M., Zhou H., Ambrosio R., Rice D.P., Acampora D., et al. Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome. EMBO Mol. Med. 2012, 4:192-205.
12. Gallego M.I., Binart N., Robinson G.W., Okagaki R., Coschigano K.T., Perry J., Kopchick J.J., Oka T., Kelly P.A., Hennighausen L. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev. Biol. 2001, 229:163-175.
13. Garnett M.J., Edelman E.J., Heidorn S.J., Greenman C.D., Dastur A., Lau K.W., Greninger P., Thompson I.R., Luo X., Soares J., et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012, 483:570-575.
14. Hennighausen L., Robinson G.W. Information networks in the mammary gland. Nat. Rev. Mol. Cell Biol. 2005, 6:715-725.
15. Jones F.E., Jerry D.J., Guarino B.C., Andrews G.C., Stern D.F. Heregulin induces invivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Differ. 1996, 7:1031-1038.
16. Keyes W.M., Wu Y., Vogel H., Guo X., Lowe S.W., Mills A.A. p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev. 2005, 19:1986-1999.
17. Klutchko S.R., Zhou H., Winters R.T., Tran T.P., Bridges A.J., Althaus I.W., Amato D.M., Elliott W.L., Ellis P.A., Meade M.A., et al. Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors. J.Med. Chem. 2006, 49:1475-1485.
18. Li L., Cleary S., Mandarano M.A., Long W., Birchmeier C., Jones F.E. The breast proto-oncogene, HRGalpha regulates epithelial proliferation and lobuloalveolar development in the mouse mammary gland. Oncogene 2002, 21:4900-4907.
19. Lim E., Vaillant F., Wu D., Forrest N.C., Pal B., Hart A.H., Asselin-Labat M.L., Gyorki D.E., Ward T., Partanen A., et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 2009, 15:907-913. kConFab.
20. Liu X., Robinson G.W., Hennighausen L. Activation of Stat5a andStat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol. Endocrinol. 1996, 10:1496-1506.
21. Liu X., Robinson G.W., Wagner K.U., Garrett L., Wynshaw-Boris A., Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 1997, 11:179-186.
22. Long W., Wagner K.U., Lloyd K.C., Binart N., Shillingford J.M., Hennighausen L., Jones F.E. Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as anobligate mediator of STAT5. Development 2003, 130:5257-5268.
23. Mills A.A., Zheng B., Wang X.J., Vogel H., Roop D.R., Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999, 398:708-713.
24. Moll U.M., Slade N. p63 and p73: roles in development and tumor formation. Mol. Cancer Res. 2004, 2:371-386.
25. Muraoka-Cook R.S., Feng S.M., Strunk K.E., Earp H.S. ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition. J.Mammary Gland Biol. Neoplasia 2008, 13:235-246.
26. Muraoka-Cook R.S., Sandahl M., Hunter D., Miraglia L., Earp H.S. Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 toinduce mammary epithelial cell gene expression differentiation. Mol. Endocrinol. 2008, 22:2307-2321.
27. Oakes S.R., Naylor M.J., Asselin-Labat M.L., Blazek K.D., Gardiner-Garden M., Hilton H.N., Kazlauskas M., Pritchard M.A., Chodosh L.A., Pfeffer P.L., et al. The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev. 2008, 22:581-586.
28. Parsa R., Yang A., McKeon F., Green H. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J.Invest. Dermatol. 1999, 113:1099-1105.
29. Polyak K., Kalluri R. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb. Perspect. Biol. 2010, 2:a003244.
30. Proia T.A., Keller P.J., Gupta P.B., Klebba I., Jones A.D., Sedic M., Gilmore H., Tung N., Naber S.P., Schnitt S., et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell Stem Cell 2011, 8:149-163.
31. Raymond K., Cagnet S., Kreft M., Janssen H., Sonnenberg A., Glukhova M.A. Control of mammary myoepithelial cell contractile function by α3β1 integrin signalling. EMBO J. 2011, 30:1896-1906.
32. Richert M.M., Schwertfeger K.L., Ryder J.W., Anderson S.M. Anatlas of mouse mammary gland development. J.Mammary Gland Biol. Neoplasia 2000, 5:227-241.
33. Rinne T., Brunner H.G., van Bokhoven H. p63-associated disorders. Cell Cycle 2007, 6:262-268.
34. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., Visvader J.E. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
35. Sleeman K.E., Kendrick H., Ashworth A., Isacke C.M., Smalley M.J. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res. 2006, 8:R7.
36. Taddei I., Deugnier M.A., Faraldo M.M., Petit V., Bouvard D., Medina D., Fässler R., Thiery J.P., Glukhova M.A. Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat. Cell Biol. 2008, 10:716-722.
37. Taverna D., Groner B., Hynes N.E. Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation. Cell Growth Differ. 1991, 2:145-154.
38. Vaillant F., Lindeman G.J., Visvader J.E. Jekyll or Hyde: does Matrigel provide a more or less physiological environment in mammary repopulating assays?. Breast Cancer Res. 2011, 13:108.
39. van Bokhoven H., Jung M., Smits A.P., van Beersum S., Rüschendorf F., van Steensel M., Veenstra M., Tuerlings J.H., Mariman E.C., Brunner H.G., et al. Limb mammary syndrome: a new genetic disorder with mammary hypoplasia, ectrodactyly, and other Hand/Foot anomalies maps to human chromosome 3q27. Am. J. Hum. Genet. 1999, 64:538-546.
40. van Bokhoven H., Hamel B.C., Bamshad M., Sangiorgi E., Gurrieri F., Duijf P.H., Vanmolkot K.R., van Beusekom E., van Beersum S.E., Celli J., et al. p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am. J. Hum. Genet. 2001, 69:481-492.
41. Van Keymeulen A., Rocha A.S., Ousset M., Beck B., Bouvencourt G., Rock J., Sharma N., Dekoninck S., Blanpain C. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011, 479:189-193.
42. Vasioukhin V., Degenstein L., Wise B., Fuchs E. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc. Natl. Acad. Sci. USA 1999, 96:8551-8556.
43. Visvader J.E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 2009, 23:2563-2577.
44. Visvader J.E., Lindeman G.J. Mammary stem cells and mammopoiesis. Cancer Res. 2006, 66:9798-9801.
45. Watson C.J., Khaled W.T. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development 2008, 135:995-1003.
46. Williams C.C., Allison J.G., Vidal G.A., Burow M.E., Beckman B.S., Marrero L., Jones F.E. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J.Cell Biol. 2004, 167:469-478.
47. Yamaji D., Na R., Feuermann Y., Pechhold S., Chen W., Robinson G.W., Hennighausen L. Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev. 2009, 23:2382-2387.
48. Yamaji D., Kang K., Robinson G.W., Hennighausen L. Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration. Nucleic Acids Res. 2013, 41:1622-1636.
49. Yang Y., Spitzer E., Meyer D., Sachs M., Niemann C., Hartmann G., Weidner K.M., Birchmeier C., Birchmeier W. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J.Cell Biol. 1995, 131:215-226.
50. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., Dötsch V., Andrews N.C., Caput D., McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 1998, 2:305-316.
51. Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R.T., Tabin C., Sharpe A., Caput D., Crum C., McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999, 398:714-718.